PROJECT SUMMARY/ABSTRACT The primary goal of this proposal is to plan for the development of and launch a sustainable Regional Center of Research Excellence (RCRE) for non-communicable diseases and injuries (NCDIs) in Rwanda. To accomplish this goal, we will establish a bi-lateral, multi-institutional, US-Rwanda collaboration to 1) conduct a rigorous landscape analysis of local infrastructure and human capacities and 2) initiate activities to address gaps in capacity for conducting NCDI research and establishing a RCRE in Rwanda. The initial focus will be on two core areas, cancer and injury, and we will conduct training and education to perform high-quality research in these core areas, and developing the electronic data infrastructure and administration needed to establish/improve disease registration for research purposes. This application leverages long- standing, pre-existing partnerships between Albert Einstein College of Medicine (AECOM), University of Rwanda (UR), Rwanda Military Hospital (RMH), Harvard University Medical School (HMS), Partners in Health (PIH), Virginia Commonwealth University (VCU), King Faisal Hospital, and the Rwanda Biomedical Center (RBC) of the Rwanda Ministry of Health (MOH). The plans for and the subsequent establishment of a RCRE in NCDI will improve the efficiency and effectiveness of research supported by each of these individual institutions by uniting efforts and fostering collaboration within the RCRE and other Rwandan stakeholders. The proposed name of the center is ?GUKORANYA? (Global University Consortium for Research in Non- communicable diseases and InjurY) Research Center (GRC). In Kinyarwanda, the national language of Rwanda, the word `gukoranya' means `to gather together'. After building the necessary research capacities and infrastructure, this center will assess the burden of cancer and injury in Rwanda and develop feasible and effective research strategies to inform the public policy and clinical practices for the prevention and treatment of these conditions.
|Effective start/end date||9/19/17 → 8/31/20|
- National Cancer Institute: $16,700.00
- National Cancer Institute: $340,631.00
- National Cancer Institute: $231,282.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.